Report no. 23/2013

Pursuant to §5 (1) (3) of the Regulation of the Minister of Finance of 19 February 2009 on current and periodic information provided by issuers of securities, the Management Board of EMC Instytut Medyczny S.A. informs about

- receiving as of 21 February 2013 an annex to the contract concluded by a subsidiary company “Lubmed” sp. z o.o. with the National Health Fund - the Dolnośląskie Voivodeship Branch in Wrocław (the Fund Branch) concerning the provision of healthcare services in the scope of outpatient specialist care in the period 1 January to 31 December 2012 as well as

- completing the assessment of healthcare services provided under the contract regarding primary health care for the period 1 January to 31 December 2012.
 

Healthcare services referred to hereinabove are provided by the subsidiary company “Lubmed” Sp. z o.o. in Lubin owned by EMC Instytut Medyczny S.A.

The Issuer informed about the contracts concluded by “Lubmed” sp. z o.o. with the Fund Branch concerning services rendered in 2012 in its current report nos. 14/2012 of 27.01.2012 and 31/2012 of 07.03.2012, 64/2012 of 21.06.2012 and 92/2012 of 06.09.2012. The Issuer informed about the contracts concerning services rendered in 2013 in its current report nos. 12/2013 of 31.01.2013 and 22/2013 of 21.02.2013.

Once the contract implementation has been assessed with regard to the provision of healthcare services such as primary health care for the period 1 January to 31 December 2012, the Fund Branch liability therefore amounts to PLN 5,822,348.56 exceeding previous estimates by PLN 123,800.56. As a result of introducing the said correction as well as signing the annex to the contract concerning rendering health care services such as outpatient specialist care, the total maximum Fund Branch liability towards the three Outpatient clinics owned by the subsidiary company “Lubmed” Sp. z o.o. in Lubin currently amounts to PLN 7,897,626.72 (an increase by PLN 102,051.13)for the period 1 January to 31 December 2012.

The other material terms of the contract with the highest value made public remain unchanged.

A criterion for a contract to be considered significant:
The value of contracts exceeds 10% of the Issuer’s equity capital.